Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis. [PDF]
Pharmacoecon Open, 2020 Background No willingness-to-pay (WTP) per quality-adjusted life-year (QALY) value exists for the Kingdom of Saudi Arabia (KSA). Objective The primary objective of this study was to determine the WTP for a QALY in the KSA.
Bazarbashi S +7 more
europepmc +3 more sources
Willingness to pay for one quality-adjusted life year in Iran [PDF]
Cost Effectiveness and Resource Allocation, 2019 Background Recent years have witnessed a strong tendency to apply economic evidence as a guide for making health resource allocation decisions, especially those related to reimbursement policies.
Najmeh Moradi +5 more
doaj +3 more sources
Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life. [PDF]
Eur J Health Econ, 2022 Cost-effective threshold (CET) is essential for health technology assessment and decision-making based on health economic evaluations. Recently, it has been argued that the commonly used once and three times of gross domestic product (GDP) per capita ...
Cai D +5 more
europepmc +2 more sources
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China. [PDF]
Appl Health Econ Health Policy, 2022 The aim of this study was to estimate the population’s willingness to pay (WTP) for an additional quality-adjusted life-year (QALY) in China. The WTP for an additional QALY (WTP/Q) was estimated using a contingent valuation survey with quota sampling and
Ye Z, Abduhilil R, Huang J, Sun L.
europepmc +2 more sources
Willingness to pay for a quality-adjusted life year among advanced non-small cell lung cancer patients in Viet Nam, 2018. [PDF]
Medicine (Baltimore), 2020 To examine the willingness to pay (WTP) for a quality-adjusted life year (QALY) gained among advanced non-small cell lung cancer (NSCLC) patients in Viet Nam and to analyze the factors affecting an individual's WTP.
Ha TV +8 more
europepmc +2 more sources
QALY-time: experts' view on the use of the quality-adjusted LIFE year in COST-effectiveness analysis in palliative care. [PDF]
BMC Health Serv Res, 2020 Background The Quality-Adjusted Life Year (QALY) is internationally recognized as standard metric of health outcomes in cost-effectiveness analyses (CEAs) in healthcare.
Wichmann AB +8 more
europepmc +2 more sources
A framework for extending the health-related quality adjusted life year by combining instruments [PDF]
Health and Quality of Life OutcomesCurrent measurement systems focus mostly on health, and not on multiple constructs of quality of life outcomes (for example health and social outcomes) together.
Brendan Mulhern +6 more
doaj +2 more sources
Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey. [PDF]
Medicine (Baltimore), 2018 Cost-effectiveness is 1 of the most important factors in medicine reimbursement, and social willingness to pay (WTP) can provide evidence for the threshold of cost-effectiveness analysis.
Song HJ, Lee EK.
europepmc +2 more sources
Estimating utility weights and quality-adjusted life year loss for colorectal cancer-related health states in Korea. [PDF]
Sci Rep, 2017 We aimed to assess utility weight of health states associated with colorectal cancer (CRC) that reflect the societal preference of the Korean population and to estimate the quality-adjusted life year (QALY) loss with CRC.
Lee JY +7 more
europepmc +2 more sources
Willingness to pay for a quality-adjusted life year in Iran: a systematic review [PDF]
Cost Effectiveness and Resource AllocationBackground The monetary value assigned to a quality-adjusted life year (QALY) serves as a fundamental threshold in cost-effectiveness evaluations, contributing to informing resource allocation decisions within healthcare systems given the more severe ...
Reza Hashempour +5 more
doaj +2 more sources